Biotech & Health Tech
WuXi Biologics, Fresenius partner ahead of biosimilar boom
WuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called an upcoming “golden decade” for such products. ...
WuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called an upcoming “golden decade” for such products. ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗